Skip to content
healthcare.dev

LEFLUNOMIDE

NDC 60505-2502, LEFLUNOMIDE, tablet, from Apotex Corp..

Product NDC
60505-2502
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077090
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2502 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEFLUNOMIDE10 mg/1

Pharmacologic classes

Antirheumatic Agent [EPC]

Package NDCNDC-11Package
60505-2502-16050525020130 TABLET in 1 BOTTLE (60505-2502-1)
60505-2502-260505250202100 TABLET in 1 BOTTLE (60505-2502-2)
60505-2502-3605052502031000 TABLET in 1 BOTTLE (60505-2502-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/753453c5-8a7a-878e-3ce7-1d1edce718a9
  • NADAC price for package 60505250201

    GET /v1/drugs/nadac/60505250201

Use it

Look up 60505-2502 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-2502 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-2502. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.